+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xiidra"

From
Ocular Inflammation Treatment Market Report 2025 - Product Thumbnail Image

Ocular Inflammation Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease. It is the first and only FDA-approved prescription eye drop that contains a combination of two active ingredients, lifitegrast and sodium hyaluronate. Xiidra works by reducing inflammation in the eyes, which can help reduce the signs and symptoms of dry eye disease. It is available in both single-use and multi-dose vials. Xiidra is a relatively new entrant to the optical disorders drugs market, but it has quickly become a popular treatment option for dry eye disease. It is generally well-tolerated and has been shown to be effective in reducing the signs and symptoms of dry eye disease. Companies in the Xiidra market include Shire, Novartis, Allergan, and Bausch + Lomb. Show Less Read more